Kimberly Gentile
Chief Tech/Sci/R&D Officer bei BIOHAVEN LTD.
Vermögen: 5 Mio $ am 31.03.2024
Profil
Frau Kimberly Gentile ist Senior Vice President-Clinical Operations bei Biohaven Pharmaceutical Holding Co. Ltd. und ein Operations Director bei Portage Pharmaceutical Ltd. Frau Gentile war zuvor als Associate Director bei Bristol Myers Squibb Co. und als Senior Manager-Clinical Trail bei SCIREX Corp. beschäftigt. Sie erwarb ihren Bachelor-Abschluss an der Salem State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOHAVEN LTD.
0,12% | 04.03.2024 | 95 969 ( 0,12% ) | 5 Mio $ | 31.03.2024 |
Aktive Positionen von Kimberly Gentile
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOHAVEN LTD. | Chief Tech/Sci/R&D Officer | - |
Portage Pharmaceutical Ltd.
 Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The private company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Chief Operating Officer | - |
Ehemalige bekannte Positionen von Kimberly Gentile
| Unternehmen | Position | Ende |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Director/Board Member | 03.10.2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.02.2014 |
| SCIREX Corp. | Corporate Officer/Principal | 01.06.2000 |
Ausbildung von Kimberly Gentile
| Salem State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| BIOHAVEN LTD. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| SCIREX Corp. | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
Portage Pharmaceutical Ltd.
Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The private company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Commercial Services |
